Search Results - "Jhingran, A"

GCIG-Consensus guideline for Long-term survivorship in gynecologic Cancer: A position paper from the gynecologic cancer Intergroup (GCIG) symptom benefit committee by Woopen, H., Sehouli, J., Davis, A., Lee, Y.C., Cohen, P.A., Ferrero, A., Gleeson, N., Jhingran, A., Kajimoto, Y., Mayadev, J., Barretina-Ginesta, M.P., Sundar, S., Suzuki, N., van Dorst, E., Joly, F.

“…•Long-term survival with gynecological cancer was defined as survival of at least five years after diagnosis.•More than 50% of long-term survivors still…”
Get full text

Erratum to “GCIG-Consensus guideline for long-term survivorship in gynecologic cancer: A position paper from the Gynecologic Cancer InterGroup (GCIG) symptom benefit committee” [Cancer Treatm. Rev. 107 (2022) 102396] by Woopen, H., Sehouli, J., Davis, A., Lee, Y.C., Cohen, P.A., Ferrero, A., Gleeson, N., Jhingran, A., Kajimoto, Y., Mayadev, J., Barretina-Ginesta, M.P., Sundar, S., Suzuki, N., van Dorst, E., Joly, F.

Get full text

Impact of Treatment Modality on Quality of Life Among Uterine Cancer Survivors by Yoder, A.K., Lakomy, D.S., Wu, J., Andring, L.M., Fellman, B., Colbert, L.E., Jhingran, A., Klopp, A.H., Soliman, P., Peterson, S.K., Lin, L.L.

“…Our understanding of the impact of adjuvant therapy on longitudinal quality of life (QoL) following surgery for patients with uterine cancer is limited. The…”
Get full text

Response to an exercise intervention after endometrial cancer: Differences between obese and non-obese survivors by Basen-Engquist, K, Carmack, C, Brown, J, Jhingran, A, Baum, G, Song, J, Scruggs, S, Swartz, M.C, Cox, M.G, Lu, K.H

“…Abstract Objective The objective of this paper is to describe baseline differences between obese and non-obese endometrial cancer survivor in anthropometrics,…”
Get full text

Definitive Extended-Field Radiation Therapy for Cervical Cancer Patients With Para-Aortic Lymph Node Metastases by Osborne, E.M, Klopp, A.H, Jhingran, A, Meyer, L, Eifel, P.J

Get full text

Patterns of Failure and Survival in Neuroendocrine Carcinoma of the Cervix by Stecklein, S.R, Burzawa, J.K, Jhingran, A, Klopp, A.H, Eifel, P.J, Frumovitz, M

Get full text

Anatomic Distribution of Inguinal Lymph Nodes in Patients With Vulvar Carcinoma by Gunther, J.R, Yang, J, Bhosale, P, Williamson, R.T, Klopp, A.H, Jhingran, A, Eifel, P.J

Get full text

Development of a Radiomics-Based Survival Prediction Model for Cervical Cancer Patients by Aristophanous, M, Cardenas, C.E, Ho, J.C, Lee, J.S, Court, L.E, Eifel, P.J, Klopp, A.H, Jhingran, A

Get full text

Factors Associated With Long-term Survival in Locally-Advanced Squamous Cell Carcinoma of the Vulva Treated With Definitive Radiation Therapy by Koay, E.J, Jhingran, A, Klopp, A.H, Levenback, C.F, Eifel, P.J

Get full text

Potential Advantages of Intensity-Modulated Radiation Therapy in Gynecologic Malignancies by Jhingran, Anuja

“…Radiation therapy (RT) plays a critical role in the management of gynecologic malignancies. Conventional RT may treat a large amount of normal tissue, which…”
Get full text

Functional Imaging Predictors of Outcome in Cervical Cancer Following Chemoradiation by Ho, J.C, Allen, P.K, Bhosale, P, Rauch, G.M, Fuller, C.D, Mohamed, A.S.R, Fruimovitz, M, Jhingran, A, Eifel, P.J, Klopp, A.H

Get full text

Comparison of CT and MRI-Based Clinical Target Volume Contours at the Time of Brachytherapy for Cervical Cancer by Swanick, C.W, Castle, K.O, Vedam, S, Turner, L.M, Yang, J, Rauch, G.M, Jhingran, A, Eifel, P.J, Klopp, A.H

Get full text

Updated 4-Year Results for NRG Oncology / RTOG 0921: A Phase 2 Study of Postoperative Intensity Modulated Radiation Therapy With Concurrent Cisplatin and Bevacizumab Followed by Carboplatin and Paclitaxel for Patients With Endometrial Cancer by Viswanathan, A.N, Winter, K, Miller, B.E, Xiao, Y, Jhingran, A, Portelance, L, Bosch, W.R, Matulonis, U, Horowitz, N, Mannel, R, Souhami, L, Erickson, B.A, Small, W, Gaffney, D.K

Get full text

Computed Tomography Consensus Clinical Target Volume Contouring for Intensity Modulated Radiation Therapy in Intact Cervical Carcinoma by Yashar, C.M, Petersen, I.A, Bosch, W.R, Albuquerque, K.V, Beriwal, S, Chino, J.P, Erickson, B.A, Feddock, J, Gaffney, D.K, Iyer, R, Klopp, A.H, Kunos, C, Mayadev, J.S, Portelance, L, Viswanathan, A.N, Wolfson, A.H, Jhingran, A, Mell, L.K

Get full text

Intensity Modulated Radiation Therapy for Vulvar Carcinoma: Changes in Practice Over 5 Years by Barkati, M, King, B, Fortin, I, Portelance, L, Viswanathan, A.N, Fyles, T.W, Beriwal, S, Alfieri, J, Lim, K.S, Harkenrider, M.M, Small, W, Klopp, A.H, Stewart, A, Yashar, C.M, Bosch, W.R, Jhingran, A, Jolicoeur, M, Gaffney, D.K

Get full text

Definitive Radiation Therapy of Locally Advanced Squamous Cell Carcinoma of the Vulva: Factors Associated With Vulvar Disease Control by Koay, E.J, Jhingran, A, Klopp, A.H, Levenback, C.F, Eifel, P.J

Get full text

Radiation injury: imaging findings in the chest, abdomen and pelvis after therapeutic radiation by Iyer, R, Jhingran, A

“…Radiation may be used as adjuvant or primary therapy in a variety of tumors in the chest, abdomen and pelvis. Therapeutic radiation affects not only malignant…”
Get full text

Survival Outcomes for Patients With Pelvic Lymph Node-Positive Stage IVB Vulvar Cancer: Time to Reconsider the FIGO Staging System? by Thaker, N, Klopp, A.H, Jhingran, A, Frumovitz, M, Iyer, R.B, Eifel, P.J

Get full text

Safety and efficacy of granisetron transdermal delivery system versus oral granisetron for prevention of chemotherapy induced nausea and vomiting in patients treated for gynecologic malignancies by Smith, J, Julius, J, Jhingran, A, Frumovitz, M

Get full text

Impact of Normal Tissue Motion on Dose to Critical Structures During Intracavitary Brachytherapy by Swanick, C.W, Castle, K.O, Cunningham, M.G, Vedam, S, Rauch, G.M, Jhingran, A, Eifel, P.J, Klopp, A.H

Get full text